A small amount (approximately ½ inch ribbon) of ointment should be applied to the conjunctival sac one to three times daily. During the initial 24 to 48 hours, the dosing frequency may be increased to one application every four hours. Care should be taken not to discontinue therapy prematurely.
If signs and symptoms fail to improve after two days, the patient should be re-evaluated (see PRECAUTIONS).
The dosing of FML ® ointment may be reduced, but care should be taken not to discontinue therapy prematurely. In chronic conditions, withdrawal of treatment should be carried out by gradually decreasing the frequency of applications.
FML ® (fluorometholone ophthalmic ointment) 0.1% is supplied in a collapsible aluminum tube with a black low density polyethylene screw cap in the following size: 3.5 g in 3.5 g tube – NDC 0023-0316-04
Store at 15°-25°C (59°-77°F). Avoid exposure to temperatures above 40°C (104°F).
Revised : 0 6 /2018
Allergan USA, Inc.
Madison, NJ 07940
© 2018 Allergan. All rights reserved.
FML® is a registered trademark of Allergan, Inc.
Allergan® and its design are trademarks of Allergan, Inc.
| FML |
|Labeler — Allergan, Inc. (144796497)|
Revised: 11/2019 Allergan, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.